Literature DB >> 33801282

Australian Experiences of Out-of-Pocket Costs and Financial Burden Following a Cancer Diagnosis: A Systematic Review.

Annie Bygrave1, Kate Whittaker1, Christine Paul2,3, Elizabeth A Fradgley2,3, Megan Varlow1, Sanchia Aranda1,4.   

Abstract

(1) Background: This systematic review was conducted to identify cancer patient experiences, and the impact of out-of-pocket costs and financial burden in Australia. (2)
Methods: A systematic review, following the Preferring Reporting Items for Systematic Reviews and Meta-Analyses, was conducted. Cumulative Index of Nursing and Allied Health Literature and PubMed were searched. The primary outcome was financial burden among cancer patients and their families in Australia. The secondary outcome was out-of-pocket costs associated with cancer care and treatment within the population sample, and the impact of financial burden. (3)
Results: Nineteen studies were included, covering more than 70,000 Australians affected by cancer. Out-of-pocket costs varied by cancer type and ranged from an average of AUD 977 for breast cancer and lymphoedema patients to AUD 11,077 for prostate cancer patients. Younger aged patients (≤65 years), Aboriginal and Torres Strait Islander people, people in rural and/or remote areas, households with low income, those who were unemployed and people with private health insurance were at increased risk of experiencing out-of-pocket costs, financial burden or a combination of both. (4) Conclusions: Australians diagnosed with cancer frequently experience financial burden, and the health and financial consequences are significant. Focusing efforts on the costs of care and options about where to have care within the context of informed decisions about cancer care is necessary.

Entities:  

Keywords:  Australia; cancer patient; financial toxicity; systematic review

Year:  2021        PMID: 33801282      PMCID: PMC7967550          DOI: 10.3390/ijerph18052422

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


  26 in total

1.  'The bills that were coming in…': out of pocket costs during relocation for specialist treatment for haematological malignancies.

Authors:  Pam McGrath
Journal:  Support Care Cancer       Date:  2016-02-04       Impact factor: 3.603

2.  Out-of-pocket expenses experienced by rural Western Australians diagnosed with cancer.

Authors:  Jade C Newton; Claire E Johnson; Harry Hohnen; Max Bulsara; Angela Ives; Sandy McKiernan; Violet Platt; Ruth McConigley; Neli S Slavova-Azmanova; Christobel Saunders
Journal:  Support Care Cancer       Date:  2018-04-27       Impact factor: 3.603

3.  Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.

Authors:  Veronica Dussel; Kira Bona; John A Heath; Joanne M Hilden; Jane C Weeks; Joanne Wolfe
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

4.  Impact of financial burden of cancer on survivors' quality of life.

Authors:  Kathleen M Fenn; Suzanne B Evans; Ruth McCorkle; Michael P DiGiovanna; Lajos Pusztai; Tara Sanft; Erin W Hofstatter; Brigid K Killelea; M Tish Knobf; Donald R Lannin; Maysa Abu-Khalaf; Nina R Horowitz; Anees B Chagpar
Journal:  J Oncol Pract       Date:  2014-05-27       Impact factor: 3.840

5.  Multiplicity of skin cancers in Queensland and their cost burden to government and patients.

Authors:  Louisa G Gordon; Thomas M Elliott; Catherine M Olsen; Nirmala Pandeya; David C Whiteman
Journal:  Aust N Z J Public Health       Date:  2017-11-22       Impact factor: 2.939

Review 6.  A Systematic Review of Financial Toxicity Among Cancer Survivors: We Can't Pay the Co-Pay.

Authors:  Louisa G Gordon; Katharina M D Merollini; Anthony Lowe; Raymond J Chan
Journal:  Patient       Date:  2017-06       Impact factor: 3.883

7.  The patient co-payment and opportunity costs of accessing healthcare for Indigenous Australians with cancer: A whole of population data linkage study.

Authors:  Emily Callander; Nicole Bates; Daniel Lindsay; Sarah Larkins; Robyn Preston; Stephanie M Topp; Joan Cunningham; Gail Garvey
Journal:  Asia Pac J Clin Oncol       Date:  2019-07-16       Impact factor: 2.601

8.  Financial toxicity, Part I: a new name for a growing problem.

Authors:  S Yousuf Zafar; Amy P Abernethy
Journal:  Oncology (Williston Park)       Date:  2013-02       Impact factor: 2.990

9.  Long-term out of pocket expenditure of people with cancer: comparing health service cost and use for indigenous and non-indigenous people with cancer in Australia.

Authors:  Emily Callander; Nicole Bates; Daniel Lindsay; Sarah Larkins; Stephanie M Topp; Joan Cunningham; Sabe Sabesan; Gail Garvey
Journal:  Int J Equity Health       Date:  2019-02-12

10.  Lifetime Costs of Surviving Cancer-A Queensland Study (COS-Q): Protocol of a Large Healthcare Data Linkage Study.

Authors:  Katharina M D Merollini; Louisa G Gordon; Joanne F Aitken; Michael G Kimlin
Journal:  Int J Environ Res Public Health       Date:  2020-04-20       Impact factor: 3.390

View more
  3 in total

1.  Patient-reported benefit from proposed interventions to reduce financial toxicity during cancer treatment.

Authors:  Emeline M Aviki; Bridgette Thom; Kenya Braxton; Andrew J Chi; Beryl Manning-Geist; Fumiko Chino; Carol L Brown; Nadeem R Abu-Rustum; Francesca M Gany
Journal:  Support Care Cancer       Date:  2021-11-25       Impact factor: 3.359

2.  Protocol for a systematic review of the financial burden experienced by people affected by head and neck cancer.

Authors:  Nikki McCaffrey; Lidia Engel
Journal:  BMJ Open       Date:  2022-02-25       Impact factor: 2.692

3.  The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas.

Authors:  Bokai Zhang; Haixin Wang; Hongyu Zhang; Guomei Tian; Ting Zhang; Qi Shi; Jian Liu; Jinpeng Xu; Jingchu Liu; Qunhong Wu; Zheng Kang
Journal:  Cost Eff Resour Alloc       Date:  2022-07-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.